Tabula Rasa HealthCare (TRHC) Earns “Overweight” Rating from Piper Jaffray Companies

Tabula Rasa HealthCare (NASDAQ:TRHC)‘s stock had its “overweight” rating reissued by investment analysts at Piper Jaffray Companies in a report released on Thursday, The Fly reports. They presently have a $80.00 price objective on the stock. Piper Jaffray Companies’ price objective suggests a potential upside of 12.53% from the company’s previous close.

Several other research firms also recently weighed in on TRHC. Stifel Nicolaus assumed coverage on shares of Tabula Rasa HealthCare in a research note on Tuesday, September 11th. They issued a “hold” rating and a $95.00 price target for the company. Cantor Fitzgerald assumed coverage on shares of Tabula Rasa HealthCare in a research note on Thursday, September 6th. They issued an “overweight” rating and a $99.00 price target for the company. BidaskClub downgraded shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 15th. Oppenheimer boosted their price target on shares of Tabula Rasa HealthCare from $65.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, August 23rd. Finally, Robert W. Baird boosted their price target on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 19th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Tabula Rasa HealthCare has a consensus rating of “Buy” and an average price target of $82.50.

Shares of NASDAQ:TRHC opened at $71.09 on Thursday. Tabula Rasa HealthCare has a 52-week low of $27.31 and a 52-week high of $91.16. The firm has a market capitalization of $1.50 billion, a P/E ratio of 209.97, a P/E/G ratio of 7.00 and a beta of 2.53. The company has a quick ratio of 0.46, a current ratio of 0.49 and a debt-to-equity ratio of 0.28.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The company had revenue of $54.42 million during the quarter, compared to analyst estimates of $52.87 million. During the same period in the previous year, the business earned $0.08 earnings per share. The firm’s quarterly revenue was up 66.3% compared to the same quarter last year. Sell-side analysts predict that Tabula Rasa HealthCare will post 0.42 EPS for the current year.

In other Tabula Rasa HealthCare news, President Orsula V. Knowlton sold 8,000 shares of the business’s stock in a transaction on Monday, September 17th. The shares were sold at an average price of $79.80, for a total value of $638,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Gordon Tunstall sold 10,000 shares of the company’s stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $70.52, for a total transaction of $705,200.00. The disclosure for this sale can be found here. Insiders sold 50,000 shares of company stock valued at $3,655,920 over the last three months. 14.00% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of the company. Rehmann Capital Advisory Group raised its stake in shares of Tabula Rasa HealthCare by 13,108.7% during the third quarter. Rehmann Capital Advisory Group now owns 3,038 shares of the company’s stock valued at $247,000 after acquiring an additional 3,015 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Tabula Rasa HealthCare by 6.9% during the third quarter. Vanguard Group Inc. now owns 967,769 shares of the company’s stock valued at $78,573,000 after acquiring an additional 62,267 shares during the last quarter. Legal & General Group Plc raised its stake in shares of Tabula Rasa HealthCare by 31.2% during the third quarter. Legal & General Group Plc now owns 36,132 shares of the company’s stock valued at $2,907,000 after acquiring an additional 8,587 shares during the last quarter. Teachers Advisors LLC raised its stake in shares of Tabula Rasa HealthCare by 2.6% during the third quarter. Teachers Advisors LLC now owns 34,204 shares of the company’s stock valued at $2,777,000 after acquiring an additional 863 shares during the last quarter. Finally, Wakefield Asset Management LLLP bought a new position in shares of Tabula Rasa HealthCare during the third quarter valued at about $269,000. 74.88% of the stock is owned by hedge funds and other institutional investors.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Featured Article: Using the New Google Finance Tool

The Fly

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply